Kilpatrick partner Charles Gray, a patent attorney and the firm’s Shanghai Office Managing Partner, recently participated in the 20th annual KTIPS (Kilpatrick Townsend Intellectual Property Seminar). The panel discussion centered on the intriguing topic of AI and Generative AI: What’s Here, What’s Coming. During the discussion, the panelists delved into the complexities of artificial intelligence and generative AI within the realm of intellectual property.
One of the key points addressed during the session was the USPTO inventorship guidelines concerning AI-assisted inventions. The panel also shed light on the expanding role of AI in drug development, as well as the utilization of AI and genAI to extend patent claims for medical devices. Furthermore, the panelists analyzed recent developments and decisions in copyright cases nationwide, emphasizing the fair use concerns associated with training data.
Mr. Gray shared three key takeaways from his segment of the presentation:
1. Understanding the evolving landscape of AI and generative AI in intellectual property is crucial for navigating future patent trends effectively.
2. The increasing integration of AI in various industries, including drug development and medical device innovation, necessitates a thorough comprehension of patent laws.
3. The ongoing debate surrounding the impact of genAI on the future of patents underscores the importance of staying informed and adaptable in the ever-changing IP landscape.
The panel discussion provided valuable insights into the intricate intersection of AI and intellectual property, highlighting the need for proactive strategies to safeguard innovation in the digital age.
